U.S. Markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
50.04-0.88 (-1.73%)
At close: 4:00PM EDT
People also watch
AMAGENTAAGIOANIKALDR
Full screen
Previous Close50.92
Open51.03
Bid0.00 x 0
Ask0.00 x 0
Day's Range49.75 - 51.04
52 Week Range42.23 - 69.85
Volume57,902
Avg. Volume106,103
Market Cap582.39M
Beta2.51
PE Ratio (TTM)109.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube4 days ago

    ETFs with exposure to ANI Pharmaceuticals, Inc. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ANI Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ANIP-US. Comparing the performance and risk of ANI Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube17 days ago

    ETFs with exposure to ANI Pharmaceuticals, Inc. : September 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ANI Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ANIP-US. Comparing the performance and risk of ANI Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017
    Capital Cube19 days ago

    ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017

    Categories: Yahoo FinanceGet free summary analysis ANI Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of ANI Pharmaceuticals, Inc. – VIVUS, Inc., Jazz Pharmaceuticals Plc, Pfizer Inc., Infinity Pharmaceuticals, Inc., Novartis AG Sponsored ADR, Mylan N.V., Lannett Company, Inc., Teva Pharmaceutical Industries Limited Sponsored ... Read more (Read more...)